{"transactions":[{"id":681751,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21731,"kind":"person","name":"Peoples George","position":1,"cik":"0002029803","reported_name":"Peoples George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2026-08-19T23:00:15.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2026, the Reporting Person was issued a non-qualified stock option to purchase 4,000 shares of common stock (the \"Options\") at an exercise price of $1.36 per share (equal to the closing price on the grant date, August 17, 2026) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 17, 2026, the Reporting Person was issued a non-qualified stock option to purchase 4,000 shares of common stock (the \"Options\") at an exercise price of $1.36 per share (equal to the closing price on the grant date, August 17, 2026) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include the stock options previously granted to the Reporting Person."}],"balance_after":4000,"derivative":{"exercise_price":1.36,"expiration_date":"2036-08-17","underlying":"Common stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001493152-26-039292","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029803/000149315226039292/ownership.xml","form_type":"4"}},{"id":1087450,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21731,"kind":"person","name":"Peoples George","position":1,"cik":"0002029803","reported_name":"Peoples George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2025-07-16T00:42:56.000Z","date":"2025-07-09","kind":"grant","planned":false,"acquired":true,"shares":137078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 15, 2025, the Reporting Person was issued a non-qualified stock option to purchase 137,078 shares of common stock (the \"Options\") at an exercise price of $0.70 per share (equal to the closing price on the grant date, July 9, 2025) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 15, 2025, the Reporting Person was issued a non-qualified stock option to purchase 137,078 shares of common stock (the \"Options\") at an exercise price of $0.70 per share (equal to the closing price on the grant date, July 9, 2025) and shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the grant date. The stock options were granted pursuant to the Issuer's non-employee director compensation policy and issued under the Issuer's 2023 Equity Incentive Plan."}],"balance_after":137078,"derivative":{"exercise_price":0.7,"expiration_date":"2035-07-09","underlying":"Common stock","underlying_shares":137078},"source":{"system":"sec-edgar","filing":"0001641172-25-019801","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029803/000164117225019801/ownership.xml","form_type":"4"}},{"id":1386813,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21731,"kind":"person","name":"Peoples George","position":1,"cik":"0002029803","reported_name":"Peoples George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2024-10-16T01:14:36.000Z","date":"2024-09-20","kind":"grant","planned":false,"acquired":true,"shares":20217,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the \"Options\") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the \"Grant Date\"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date."}],"balance_after":20217,"derivative":{"exercise_price":1.09,"expiration_date":"2034-09-20","underlying":"Common stock","underlying_shares":20217},"source":{"system":"sec-edgar","filing":"0001493152-24-041200","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029803/000149315224041200/ownership.xml","form_type":"4"}},{"id":1456378,"issuer":{"id":8408,"kind":"organization","name":"Calidi Biotherapeutics, Inc."},"owners":[{"id":21731,"kind":"person","name":"Peoples George","position":1,"cik":"0002029803","reported_name":"Peoples George","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2024-07-11T20:53:47.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":30904,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on July 1, 2024 (the \"Grant Date\"), the Reporting Person was granted 30,904 non-qualified stock options (the \"Options\") at the exercise price of $0.193, which is the closing price of the Issuer's common stock on the Grant Date. The Options shall vest in 1/36 per month over three years, commencing on the Grant Date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Issuer's 2023 Equity Incentive Plan (the \"2023 Plan\"), on July 1, 2024 (the \"Grant Date\"), the Reporting Person was granted 30,904 non-qualified stock options (the \"Options\") at the exercise price of $0.193, which is the closing price of the Issuer's common stock on the Grant Date. The Options shall vest in 1/36 per month over three years, commencing on the Grant Date."}],"balance_after":30904,"derivative":{"exercise_price":0.193,"expiration_date":"2034-07-01","underlying":"Common stock","underlying_shares":30904},"source":{"system":"sec-edgar","filing":"0001493152-24-026971","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2029803/000149315224026971/ownership.xml","form_type":"4"}}]}